Summary & Overview
CPT 4011F: Prescription of Antiplatelet Therapy to Prevent Thrombosis
CPT code 4011F documents when a clinician prescribes an antiplatelet medication to prevent platelets from aggregating and thereby reduce the risk of myocardial infarction and ischemic stroke. Nationally, capturing this clinical action with a discrete code supports quality measurement, care coordination, and population-level tracking of secondary prevention strategies for cardiovascular disease. Common settings for this service include outpatient primary care and cardiology clinics where ongoing medication management and follow-up occur.
Key payers addressed in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a compact briefing on the clinical intent of the code, the service context, and what to expect from payer coverage patterns and quality measurement use. The publication outlines standard benchmarks and reporting uses where available, summarizes relevant policy considerations affecting documentation and billing for antiplatelet therapy prescriptions, and provides clinical context about the role of antiplatelet agents in preventing thrombotic events. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 4011F indicates that the provider prescribes a drug that prevents platelets from sticking together, reducing the risk of heart attack and stroke. This service represents prescription management of antiplatelet therapy aimed at preventing thrombotic cardiovascular events.
-
Service type: Prescription medication management for antiplatelet therapy
-
Typical site of service: Outpatient clinic, primary care office, cardiology clinic, or other ambulatory care settings where medication management and follow-up occur
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with established atherosclerotic cardiovascular disease or multiple cardiovascular risk factors who is seen in outpatient primary care or cardiology clinic for secondary prevention counseling and medication management. The clinician assesses history of myocardial infarction, ischemic stroke, transient ischemic attack, coronary artery stenting, peripheral arterial disease, or high-risk coronary anatomy, and determines the need to initiate or continue an antiplatelet agent (for example aspirin, clopidogrel, ticagrelor, prasugrel). The workflow includes medication reconciliation, review of bleeding risk and allergies, discussion of indication and expected duration, documentation of informed consent when applicable, and e-prescribing or handwritten prescription generation. Typical site of service is outpatient clinic (primary care or cardiology), ambulatory surgical center when prescribed peri-procedurally, or hospital inpatient medical service when started during admission for acute coronary syndrome or stroke. The common patient scenario: a 68-year-old man with prior myocardial infarction and coronary stent presents for follow-up; clinician documents ongoing need for antiplatelet therapy and prescribes a P2Y12 inhibitor to reduce risk of recurrent myocardial infarction and stroke, with counseling on adherence and bleeding precautions.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Use when no special reporting modifier applies; default state for most claims |